SCHEMBL17902502

SCHEMBL17902502

C[C@H](N)C(=O)O[C@@H](C)C(c1ccc(-c2ccccc2)cc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 1/20 0.49
▸ TAAR1 Q96RJ0 1/20 0.46
▸ PDCD1 Q15116 1/20 0.45
▸ CD274 Q9NZQ7 1/20 0.45
▸ PRCP P42785 2/20 0.43
▸ GAA P10253 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ ACACB O00763 1/20 0.41
▸ ACACA Q13085 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ SLC1A5 Q15758 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17901984 0.90 KMT2A (0.43) CYP1A2PKMSMN1; SMN2ALDH1A1
SCHEMBL17902366 0.90 KMT2A (0.43) CYP1A2PKMSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL19460524 0.89 ALDH1A1 (0.43) CYP1A2PKMSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL19460525 0.89 ALDH1A1 (0.43) CYP1A2PKMSMN1; SMN2ALDH1A1
SCHEMBL17902599 0.86 LMNA (0.45) ALDH1A1HPGD
SCHEMBL17902593 0.86 LMNA (0.45) ALDH1A1HPGD
SCHEMBL17902591 0.85 NPC1 (0.46) GAACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL17902439 0.85 NPC1 (0.46) GAACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL26321522 0.85 NPC1 (0.46) GAACYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL17902579 0.83 RAB9A (0.39) CYP1A2CYP2C9CYP2C19MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11751568-B2 Picolinamide compounds with fungicidal activity CORTEVA AGRISCIENCE LLC (US) 2023-09-12 — — US disclosed
US-11751568-B2 Picolinamide compounds with fungicidal activity CORTEVA AGRISCIENCE LLC (US) 2023-09-12 — — US disclosed
EP-3808181-A1 USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES Dow AgroSciences LLC (US) 2021-04-21 — — EP disclosed
EP-3240773-B9 PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC (US) 2021-01-13 — — EP disclosed
EP-3240424-B1 USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2020-09-16 — — EP disclosed
EP-3240773-B1 PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC (US) 2020-06-03 — — EP disclosed
US-10588318-B2 Picolinamide compounds with fungicidal activity DOW AGROSCIENCES LLC (US) 2020-03-17 — — US disclosed
US-10182568-B2 Use of picolinamide compounds as fungicides DOW AGROSCIENCES LLC (US) 2019-01-22 — — US disclosed
WO-2016122802-A1 PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC (US) 2016-08-04 — — WO disclosed
WO-2016109257-A1 USE OF PICOLINAMIDE COMPOUNDS AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2016-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10182568-B2 Use of picolinamide compounds as fungicides PFAS, FKBP2, FKBP14 PTGS2 1378/4885TAAR1 2727/4885PDCD1 872/4885
US-11751568-B2 Picolinamide compounds with fungicidal activity PFAS, CASP2, CYP1A2 PTGS2 1590/4885TAAR1 3451/4885PDCD1 961/4885
US-10588318-B2 Picolinamide compounds with fungicidal activity PFAS, CASP2, CYP1A2 PTGS2 1590/4885TAAR1 3451/4885PDCD1 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback